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Abstract 
BACKGROUND: Sepsis is a significant cause of morbidity and mortality in children. The diagnosis of sepsis 
remains continuing to develop which determines treatment and prognostic. Antithrombin III is one of the 
coagulation markers to evaluate the prognosis of sepsis. 
AIM: To determine the association between the level of antithrombin III and mortality in children with sepsis in the 
Pediatric Intensive Care Unit, Haji Adam Malik General Hospital, Medan. 
METHODS: A cross-sectional study was conducted in Haji Adam Malik General Hospital, Medan from April until 
June 2015. There were 41 children with sepsis. Sepsis was diagnosed from clinical and laboratory findings. 
Complete blood count, antithrombin III level, C-reactive protein and procalcitonin were an indicator of unproven 
sepsis that performed in the laboratory. Meanwhile blood culture was performed in the microbiology laboratory. 
The association between the level of antithrombin III and mortality was analysed by using chi-square test. 
RESULTS: Of the 41 participants, the low antithrombin III level was 13 of 41 children (31.7%) meanwhile the 
normal antithrombin III level was 28 of 41 children (68.3%). There was 8 of 13 (42.1%) and 11 of 28 (57.9%) 
children in death cases of low and normal antithrombin III level, respectively. Samples with low antithrombin III 
level had 2.473 higher risk mortality than normal antithrombin III level (P = 0.184; 95% CI 0.641 to 9.5421; PR = 
2.473). 
CONCLUSION: There was no statistically significant association between levels of antithrombin III and mortality 
in children with sepsis. 
 
 
 
 
 
Introduction 
 
Sepsis is one of the causes of mortality 
amongst children worldwide. It is defined as systemic 
inflammatory response syndrome (SIRS) which 
caused by infection either proven by clinical 
examination, blood culture or septic markers [1], [2], 
[3].
 
The incidence of sepsis was 0.56 cases per 1000 
children per year, the highest amongst infants (5.16 
per 1000) and decreased with ages (0.20 per 1000 
among 10-14-year-olds) [4]. The development of 
diagnostic of sepsis is the main key to treatment and 
prognostic determination [5], [6].
 
Antithrombin III is an inhibitor of thrombin-
mediated vascular injury in the microcirculation during 
severe sepsis. This endogenous anticoagulant is 
rapidly depleted in the early phases of sepsis as a 
result of decreased synthesis, increased destruction, 
and enhanced clearance by thrombin-antithrombin 
complex formation [7].
 
Examination of antithrombin III 
(ATIII) will be able to be an objective and reliable 
examination in detecting sepsis circumstances, in 
determining the severity and differentiate various 
possible causes of sepsis and can be used to 
measure the response to treatment [5], [6]. 
A study in Turkey, 2007, showed that the 
value of initial antithrombin III (ATIII) level could be 
used as a prognostic factor in neonatal sepsis. From 
this study was reported that the initial antithrombin III 
(ATIII) level decreased in patients with sepsis and 
could predict mortality [7].
 
However, the antithrombin III level, as a 
prognostic factor, in children has never been reported; 
this is the background of this study to determine the 
association between antithrombin III (ATIII) level and 
mortality in children with sepsis. 
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Methods 
 
Study Design  
A cross-sectional study was conducted to 
determine the association between the level of 
antithrombin III and mortality in children with sepsis 
Pediatric Intensive Care Unit, Haji Adam Malik 
General Hospital, Medan, North Sumatera, Indonesia 
from April until June 2015. Sepsis was diagnosed with 
by clinical examination, blood culture or septic 
markers. The inclusion criteria are children with sepsis 
from 6 months to 18 years old.  
The exclusion criteria are patients with blood 
disorders because the level of antithrombin III was 
decreased in blood disorders. Samples were obtained 
by consecutive sampling. Data were analysed by 
statistical software, and the result was presented in 
tables. This study was approved by the Health 
Research Ethical Committee, Medical School, 
University of Sumatera Utara.  
 
Sample Recruitment 
All subject who fulfilled the inclusion criteria 
were enrolled in this study. Data patients about sex, 
mean age, body weight, stature, nutrition status, data 
laboratory (Routine blood, antithrombin III, C-reactive 
protein (CRP), procalcitonin and blood culture) were 
collected from medical records. 
On the first day of treatment, all subjects were 
suspected as sepsis based on clinical findings; 
samples had laboratory tests such as routine blood, 
antithrombin III, C-reactive protein (CRP), 
procalcitonin and blood culture. Antithrombin III (ATIII) 
level is part of the coagulation examination. Blood was 
taken at least 1.8 mL from the cubital vein. The blood 
inserted into a citrate tube and transported to the 
laboratory according to the Standard  
Operating Procedure. Examination of ATIII 
level is carried out using Teco Coatron AT III. The 75-
150% value of antithrombin III (ATIII) is a normal 
category, and the < 75% value of antithrombin III 
(ATIII) is a low category [8].
 
Samples were followed-up 
until death or discharged from the paediatric intensive 
care unit. 
 
Statistical Analysis 
The association between the level of 
antithrombin III and mortality in children with sepsis 
was analysed using chi-square with a 95% confidence 
interval and P-value < 0.05 was considered 
significant. 
 
 
Results 
 
Of 41 patients were enrolled in this study. 
Baseline characteristics samples were described in 
Table 1. shows the baseline characteristics of 
patients, including sex, mean age, body weight, 
stature, nutrition status, data laboratory (Routine 
blood, antithrombin III, C-reactive protein (CRP), 
procalcitonin and blood culture). There was no 
association between sex, mean age, nutrition status, 
CRP, blood culture, mean leukocyte, mean platelets, 
mean procalcitonin to mortality in this study. There 
was an association (p = 0.024) between mean 
haemoglobin in the death group (10.26 g/dl) and life 
group (11.54 g/dl). 
Table 1: Baseline characteristics samples 
Characteristics Mortality Death Life p 
Sex (n%) 
Boys 
Girls 
Mean Age (years) 
Nutritional Status (n%) 
Malnutrition 
Normal 
CRP (n%) 
Positive 
Negative 
Blood Culture (n%) 
Positive 
Negative  
Mean Haemoglobin(g/dl)  
Mean leukocyte  
(mm
3
)  
Mean Platelets  
(mm
3
) 
Mean Procalcitonin 
 
12 (52.2) 
7 (38.9) 
7.95 (5.49) 
 
4 (66.7) 
15 (42.9) 
 
18 (48) 
1 (25) 
 
1 (20) 
18 (50) 
10.26 (2.17) 
15.165 
(9567) 
276.173 
(188.333) 
9.09 (13.44) 
 
11(47.6) 
11(61.6) 
8.71 (5.38) 
 
2 (33.3) 
20 (57.1) 
 
19 (51.4) 
3 (75) 
 
4 (80) 
18(50) 
11.54 (1.26) 
14.927 
(5270) 
222.256 
(129.778) 
15.56 (41.86) 
 
0.397
a
 
 
0.656
b 
 
0.390
d 
 
 
0.610
d 
 
 
0.350
d 
 
0.024
b 
0.979
c 
 
0.488
c 
 
0.875
c
 
s 
Chi-Square; 
b 
T independent; 
c 
Mann Whitney; 
d 
Fisher’s Exact. 
 
Table 2: Association between the level of antithrombin III and 
mortality 
Antithrombin III Mortality P PR 95% CI 
Yes No 
Low 
Normal 
8 (42.1) 
11 (57.9) 
5 (22.7) 
17 (77.3) 
0.184 2.473 0.641-9.542 
 
Chi-square test was used to determine the 
association between the value of antithrombin III 
(ATIII) and mortality in children with sepsis (Table 2). 
Antithrombin III was classified as normal if the level of 
antithrombin III was 75% until 150% and low if the 
level of antithrombin III was < 75% [8]. According to 
the test’s result, there was no statistically significant 
association between levels of antithrombin III and 
mortality in this study (p = 0.184). 
 
 
Discussion 
 
Sepsis is a group of signs of systemic 
inflammation due to infection based on clinical 
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examination or proven by blood culture and septic 
markers [1], [2], [3]. Sepsis is one of the common 
reason for mortality in infants and children Who 
reported that 70 per cent of 8 million mortality of 
children under five years old in developing countries 
was caused by infectious diseases in which ended up 
to sepsis [4].
 
In 2007, Indonesia Basic Health 
Research reported that sepsis was the most common 
reason for infant mortality (20.5%) [9].
 
The sepsis diagnostic approach is currently to 
determine early signs of sepsis, evaluate treatment 
and make prognosis [5], [10].
 
Antithrombin III is a useful prognostic marker 
in sepsis, due to its potential inhibitor of thrombin 
which occurs when there is a vascular injury in 
microcirculation during the process of infection. Many 
previous studies have reported that initial AT levels of 
patients with sepsis who developed septic shock and 
DIC are an indicator of prognosis and cases with very 
low AT levels have a higher mortality rate [7].
 
A study 
in Europe, 2006, showed that low activity of 
antithrombin III was correlated with severity and 
survival rate in patients with sepsis [11]. 
A study in Korea, 2014, showed that 
antithrombin and protein C were strong prognostic 
markers patients with DIC, sepsis or severe sepsis 
[12]. The same conclusion also found in a study in 
Thailand, 2006, where the reduced level of protein C, 
protein S and antithrombin might predict the survival 
rate of gram-negative sepsis due to Burkholderia 
pseudomallei [13].
 
This study shows that there is no statistically 
significant association between levels of antithrombin 
III and mortality in this study (p = 0.184). Low level of 
antithrombin III in the subjects who died was 8 subject 
(42.1%) and with normal levels were found in 11 
subject (57.9%). Although not statistically significant, 
there showed that subjects with a low level of 
antithrombin III in patients with sepsis had 2.473 
higher risk for caused mortality compared with the 
normal level of antithrombin III (P = 0.184; 95% CI 
0.641 to 9.5421; PR = 2.473).
 
The limitation of this study did not compare to 
other haematology markers examinations, so it could 
not evaluated that specificity and sensitivity. This 
study was needed more fourth researches to 
determine the level of antithrombin III as a prognostic 
marker in children sepsis. 
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